Pharma & Biotech

Shares of Australian biotechnology firm Mesoblast Limited experienced significant downward momentum in recent trading sessions. The company's stock listed on...

The biosimulation company Simulations Plus finds itself navigating the most turbulent period in its recent history. A combination of legal...

Biotechnology firm United Therapeutics enters a pivotal period as market participants await a major medical conference presentation. The company's stock...

Friday proved to be a turbulent day for pharmaceutical giant Eli Lilly, with three significant developments creating a complex picture...

Medical device specialist Utah Medical Products is confronting significant headwinds, with its latest quarterly results revealing a pronounced contraction in...

Danish pharmaceutical giant Novo Nordisk is implementing a sweeping cost-cutting initiative that carries substantial near-term pain. The company's ambitious plan...

Telehealth provider Hims & Hers Health is making a bold strategic move to capture a significant share of the lucrative...

Shares of Merit Medical Systems are trading quietly around $93.24 as investors monitor two significant near-term developments. Market attention remains...

The biopharmaceutical company Larimar Therapeutics enters a decisive period with two significant clinical milestones scheduled for September 2025. These events...

Moderna's stock remains under significant pressure despite achieving a critical regulatory milestone. The U.S. Food and Drug Administration recently granted...